Intermountain Health Care, Inc.
Quick facts
Marketed products
- Dosing of enoxaparin for VTE prophylaxis · Cardiovascular
Enoxaparin is a low-molecular-weight heparin that inhibits blood clotting by enhancing the activity of antithrombin III against factors Xa and IIa.
Phase 2 pipeline
Phase 1 pipeline
- Alvimopam · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: